Highly recurrent RET mutations and novel mutations in genes of the receptor tyrosine kinase and endothelin receptor B pathways in Chinese patients with sporadic Hirschsprung disease.

IF 7.1 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY
Clinical chemistry Pub Date : 2004-01-01 Epub Date: 2003-11-18 DOI:10.1373/clinchem.2003.022061
Mercè Garcia-Barceló, Mai-Har Sham, Wing-Shan Lee, Vincent Chi-Hang Lui, Benedict Ling-Sze Chen, Kenneth Kak-Yuen Wong, Joyce Suet-Wan Wong, Paul Kwong-Hang Tam
{"title":"Highly recurrent RET mutations and novel mutations in genes of the receptor tyrosine kinase and endothelin receptor B pathways in Chinese patients with sporadic Hirschsprung disease.","authors":"Mercè Garcia-Barceló,&nbsp;Mai-Har Sham,&nbsp;Wing-Shan Lee,&nbsp;Vincent Chi-Hang Lui,&nbsp;Benedict Ling-Sze Chen,&nbsp;Kenneth Kak-Yuen Wong,&nbsp;Joyce Suet-Wan Wong,&nbsp;Paul Kwong-Hang Tam","doi":"10.1373/clinchem.2003.022061","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hirschsprung disease (HSCR) is a congenital disorder characterized by an absence of ganglion cells in the nerve plexuses of the lower digestive tract. HSCR has a complex pattern of inheritance and is sometimes associated with mutations in genes of the receptor tyrosine kinase (RET) and endothelin receptor B (EDNRB) signaling pathways, which are crucial for development of the enteric nervous system.</p><p><strong>Methods: </strong>Using PCR amplification and direct sequencing, we screened for mutations and polymorphisms in the coding regions and intron/exon boundaries of the RET, GDNF, EDNRB, and EDN3 genes of 84 HSCR patients and 96 ethnically matched controls.</p><p><strong>Results: </strong>We identified 10 novel and 2 previously described mutations in RET, and 4 and 2 novel mutations in EDNRB and in EDN3, respectively. Potential disease-causing mutations were detected in 24% of the patients. The overall mutation rate was 41% in females and 19% in males (P = 0.06). RET mutations occurred in 19% of the patients. R114H in RET was the most prevalent mutation, representing 7% of the patients or 37% of the patients with RET mutations. To date, such a high frequency of a single mutation has never been reported in unrelated HSCR patients. Mutations in EDNRB, EDN3, and GDNF were found in four, two, and none of the patients, respectively. Two patients with mutations in genes of the EDNRB pathway also harbored a mutation in RET. Three novel and three reported polymorphisms were found in EDNRB, EDN3, and GDNF.</p><p><strong>Conclusion: </strong>This study identifies additional HSCR disease-causing mutations, some peculiar to the Chinese population, and represents the first comprehensive genetic analysis of sporadic HSCR disease in Chinese.</p>","PeriodicalId":10690,"journal":{"name":"Clinical chemistry","volume":"50 1","pages":"93-100"},"PeriodicalIF":7.1000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1373/clinchem.2003.022061","citationCount":"62","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1373/clinchem.2003.022061","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2003/11/18 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 62

Abstract

Background: Hirschsprung disease (HSCR) is a congenital disorder characterized by an absence of ganglion cells in the nerve plexuses of the lower digestive tract. HSCR has a complex pattern of inheritance and is sometimes associated with mutations in genes of the receptor tyrosine kinase (RET) and endothelin receptor B (EDNRB) signaling pathways, which are crucial for development of the enteric nervous system.

Methods: Using PCR amplification and direct sequencing, we screened for mutations and polymorphisms in the coding regions and intron/exon boundaries of the RET, GDNF, EDNRB, and EDN3 genes of 84 HSCR patients and 96 ethnically matched controls.

Results: We identified 10 novel and 2 previously described mutations in RET, and 4 and 2 novel mutations in EDNRB and in EDN3, respectively. Potential disease-causing mutations were detected in 24% of the patients. The overall mutation rate was 41% in females and 19% in males (P = 0.06). RET mutations occurred in 19% of the patients. R114H in RET was the most prevalent mutation, representing 7% of the patients or 37% of the patients with RET mutations. To date, such a high frequency of a single mutation has never been reported in unrelated HSCR patients. Mutations in EDNRB, EDN3, and GDNF were found in four, two, and none of the patients, respectively. Two patients with mutations in genes of the EDNRB pathway also harbored a mutation in RET. Three novel and three reported polymorphisms were found in EDNRB, EDN3, and GDNF.

Conclusion: This study identifies additional HSCR disease-causing mutations, some peculiar to the Chinese population, and represents the first comprehensive genetic analysis of sporadic HSCR disease in Chinese.

中国散发性巨结肠病患者高复发性RET突变和受体酪氨酸激酶和内皮素受体B通路基因的新突变
背景:巨结肠病(HSCR)是一种先天性疾病,其特征是下消化道神经丛中神经节细胞的缺失。HSCR具有复杂的遗传模式,有时与受体酪氨酸激酶(RET)和内皮素受体B (EDNRB)信号通路的基因突变有关,这对肠神经系统的发育至关重要。方法:采用PCR扩增和直接测序的方法,筛选84例HSCR患者和96例种族匹配对照者的RET、GDNF、EDNRB和EDN3基因编码区和内含子/外显子边界的突变和多态性。结果:我们在RET中发现了10个新的突变和2个先前描述的突变,在EDNRB和EDN3中分别发现了4个和2个新的突变。24%的患者检测到潜在的致病突变。总体突变率女性为41%,男性为19% (P = 0.06)。19%的患者发生了RET突变。RET中的R114H是最常见的突变,占RET突变患者的7%或37%。迄今为止,在没有血缘关系的HSCR患者中从未报道过如此高频率的单一突变。EDNRB、EDN3和GDNF突变分别在4例、2例和0例患者中发现。两名EDNRB通路基因突变的患者也携带RET突变。在EDNRB、EDN3和GDNF中发现了三种新的和三种已报道的多态性。结论:本研究发现了更多的HSCR致病突变,其中一些是中国人群特有的,并且首次对中国散发性HSCR疾病进行了全面的遗传分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical chemistry
Clinical chemistry 医学-医学实验技术
CiteScore
11.30
自引率
4.30%
发文量
212
审稿时长
1.7 months
期刊介绍: Clinical Chemistry is a peer-reviewed scientific journal that is the premier publication for the science and practice of clinical laboratory medicine. It was established in 1955 and is associated with the Association for Diagnostics & Laboratory Medicine (ADLM). The journal focuses on laboratory diagnosis and management of patients, and has expanded to include other clinical laboratory disciplines such as genomics, hematology, microbiology, and toxicology. It also publishes articles relevant to clinical specialties including cardiology, endocrinology, gastroenterology, genetics, immunology, infectious diseases, maternal-fetal medicine, neurology, nutrition, oncology, and pediatrics. In addition to original research, editorials, and reviews, Clinical Chemistry features recurring sections such as clinical case studies, perspectives, podcasts, and Q&A articles. It has the highest impact factor among journals of clinical chemistry, laboratory medicine, pathology, analytical chemistry, transfusion medicine, and clinical microbiology. The journal is indexed in databases such as MEDLINE and Web of Science.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信